HANDELSBANKEN FONDER AB – Alnylam Pharmaceuticals, Inc. Transaction History
HANDELSBANKEN FONDER AB portfolio value:
$25.53M
portfolio value
HANDELSBANKEN FONDER AB quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -25.82% | -44.40K shares | 453K | $200.16 | 127.59K |
| Q2 2022 | share | Increase | +0.35% | 600 shares | -2.90M | $145.85 | 172K |
| Q1 2022 | share | Decrease | -8.73% | -16.4K shares | -3.85M | $163.29 | 171.4K |
| Q4 2021 | share | Increase | +834.33% | 167.7K shares | 28.05M | $171.03 | 187.8K |
| Q3 2021 | share | Increase | +5.24% | 1K shares | 557K | $188.81 | 20.1K |
| Q2 2021 | share | Decrease | -5.91% | -1.2K shares | 372K | $169.52 | 19.1K |
| Q1 2021 | share | Decrease | -6.45% | -1.4K shares | 46K | $141.19 | 20.3K |
| Q4 2020 | share | Increase | +13.02% | 2.5K shares | 24K | $129.97 | 21.7K |
| Q3 2020 | share | 0.00% | 0 shares | -48K | $145.6 | 19.2K | |
| Q2 2020 | share | Increase | 0.00% | 19.2K shares | 2.84M | $148.11 | 19.2K |
| Q1 2016 | share | Decrease | -100.00% | -6.34K shares | -598K | $62.77 | 0 |